GSK (LSE:GSK) recently announced the FDA approval of Blujepa, a first-in-class antibiotic for urinary tract infections, and ...

Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes.

The FDA has approved GSK's gepotidacin, the first oral antibiotic to offer a new mechanism of action in uncomplicated urinary tract infections (uUTIs) in nearly 30 years, after a priority review.

The FTSE 100 tumbled 2.92 percent on Wednesday, shedding 231.05 points to close at 7,679.48 points as U.S. President ...

In a jobs market marred by a hiring slowdown, Staffline (STAF) appears to be bucking the trend. Unlike its larger peers, the Aim-listed blue-collar recruiter grew revenue, underlying operating profits ...

Fear returned to the world’s stock markets today after Donald Trump’s swingeing new “Liberation Day” tariffs came into force.

British equities tumbled on Wednesday led by declines in healthcare and energy stocks, as U.S. tariffs took effect, ...

He says the S&P 500 edged "increasingly close to bear market territory," having shed 18.9% since its peak in mid-February and ...

As the global trade war scaled up, the FTSE 100 was back in the red on Wednesday and reversed gains made at the start of the ...

The FTSE 100 index is seen surging by about 5% after President Trump’s tariffs pause last night triggered a relief rally for ...

We recently published a list of 20 Stocks Insiders Bought in April After Trump’s Tariff Rollout. In this article, we are ...